Market data not licensed for redistribution.

Oscotec

039200 · KOSDAQ · Pharmaceuticals Manufacturing

– Previous close pending (official data.go.kr feed not active yet) Live price ↗

Source: Financial Services Commission stock price data (data.go.kr), updated once a day.

Daily price, 1 year

Key statistics

Market cap (KRW bn)–

PER–

PBR–

ROE %44.8

Debt ratio % (liabilities / equity)19

Revenue TTM (KRW bn)144.2

Op. profit TTM (KRW bn)89.7

Dividend yield %–

Basis: market cap at …; equity = total equity (consolidated if available) at 2026.06.30; net income = trailing 12 months to 2026.06.30 (consolidated). PER is not shown when TTM net income is negative.

Upcoming risk events

Next 90 days for this company, plus macro events tagged with this ticker or its sector. Not a recommendation.

No scheduled risk events found (last checked 2026-10-30 19:40 KST).

Other scheduled dates (routine, not risks) (1)

2026-11-30 · Routine schedule: extraordinary shareholder meeting

See it in the full calendar →

Annual results (KRW bn)

	2021	2022	2023	2024	2025
Revenue	3.9	5.1	5.0	34.0	99.8
Operating profit	-28.1	-28.6	-32.7	-2.7	52.1
Net income	-28.6	-27.8	-28.5	-1.6	54.4

Quarterly results (KRW bn, 3 months)

	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1	2026Q2
Revenue	1.9	10.0	8.9	78.9	3.6	52.6
Operating profit	-8.3	-0.6	-0.4	61.4	-10.0	38.7
Net income	-7.8	-2.5	0.6	64.0	-5.0	40.8

Largest shareholder

As of the 2025 annual report: 김정근 and related parties hold 12.67% of common shares.

Recent disclosures

Date	Filing
2026-10-06	Shareholder meeting 주주명부폐쇄기간또는기준일설정	DART original
2026-10-06	Shareholder meeting 주주총회소집결의 (임시주주총회)	DART original
2026-09-23	Litigation 소송등의제기ㆍ신청(경영권분쟁소송)	DART original
2026-09-18	Insider / major-holder ownership report [기재정정]주식등의대량보유상황보고서(일반)	DART original
2026-09-17	Insider / major-holder ownership report 주식등의대량보유상황보고서(일반)	DART original
2026-09-17	Insider / major-holder ownership report 주식등의대량보유상황보고서(약식)	DART original
2026-09-04	Clinical trial / regulatory approval 투자판단관련주요경영사항(임상시험결과) (알츠하이머 치료 후보물질 ADELY01 임상 1a/1b상 임상시험결과보고서(CSR) 수령)	DART original
2026-09-01	Insider / major-holder ownership report 주식등의대량보유상황보고서(일반)	DART original
2026-08-20	IR event 기업설명회(IR)개최	DART original
2026-08-14	Insider / major-holder ownership report 주식등의대량보유상황보고서(일반)	DART original
2026-08-14	Periodic report (annual/half/quarterly) 반기보고서 (2026.06)	DART original
2026-07-23	Change of largest shareholder [기재정정]최대주주변경	DART original

Past material filings and price reaction (market-adjusted)

Date	Filing type	On the news (vs. market)	Next day (vs. market)	20 days (vs. market)
2026-09-23	Litigation	+1.0%	-2.8%	–
2026-09-04	Clinical trial / regulatory approval	-1.2%	-1.7%	-0.7%
2026-06-01	Other material event (investment-relevant)	+15.2%	-7.9%	-9.7%
2026-05-22	Clinical trial / regulatory approval	+0.5%	-1.6%	+10.1%
2026-05-14	Technology licensing / alliance	-1.1%	+4.1%	-4.5%
2026-03-20	Litigation	-4.2%	-0.7%	-3.1%
2026-03-19	Clinical trial / regulatory approval	+0.8%	-5.0%	-4.1%
2026-03-11	Litigation	+1.4%	-2.1%	+4.4%
2026-03-06	Litigation	-1.6%	+4.7%	+5.0%
2026-02-27	Revenue/profit change >=30% (15% large caps)	+3.5%	+7.6%	+3.5%

For information only, not investment advice. Data may be delayed or inaccurate. Full disclaimer → Data: OpenDART (FSS), stock prices: official previous-day close from the Financial Services Commission (data.go.kr) and FinanceData/marcap history, index data via FinanceDataReader, FX: ECB reference rates, crypto data from Upbit, Bithumb and Binance public APIs.
Market data not licensed for redistribution.
© Crypvu · Crypto market view